Allergic Maculo-Papular Exanthema Due To Terbinafine

AndrÃ© Koch; Georgi Tchernev; Uwe Wollina

doi:10.3889/oamjms.2017.105

Authors

AndrÃ© Koch Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden
Georgi Tchernev Department of Dermatology, Venereology and Dermatologic Surgery, Medical Institute of Ministry of Interior, and Onkoderma Policlinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria
Uwe Wollina Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden

DOI:

https://doi.org/10.3889/oamjms.2017.105

Keywords:

Terbinafine, Exanthema, Antimycotic drugs, Type-IV allergies, Patch test, Prick test

Abstract

We report on a 76-year-old male patient who developed a maculopapular generalised exanthema due to terbinafine. Prick test was negative; patch test revealed a positive reaction after 48 h confirming the delayed-type allergic reaction. Non-pustular exanthema has only rarely been reported for terbinafine.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Favre B, Ryder NS. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrob Agents Chemother. 1996;40:443-447. PMid:8834895 PMCid:PMC163131

Ozturk G, Turk BG, Karaca N et al. Generalised pustular eruptions due to terbinafine. Cutan Ocul Toxicol. 2012;31:81-84. https://doi.org/10.3109/15569527.2011.607202 PMid:21888496

George A, Bhatia A, Kanish B, Williams A. Terbinafine-induced pityriasis rosea-like eruption. Indian J Pharmacol. 2015;47:680-681. https://doi.org/10.4103/0253-7613.169574 PMid:26729964 PMCid:PMC4689026

Sidoroff A. Acute generalised exanthematous pustulosis. Hautarzt. 2014;65: 430-435. https://doi.org/10.1007/s00105-013-2698-7 PMid:24820800

Veraldi S, Pontini P, Serini SL. Terbinafine and taste loss. G Ital Dermatol Venereol. 2016;151:308-309. PMid:27176083

Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of Drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011;164(3):465-472. https://doi.org/10.1111/j.1365-2133.2010.10110.x

Verros CD, Rallis E. The role of terbinafine in the induction and exacerbation of psoriasis. Int J Dermatol. 2013;52:1155â€“1156. https://doi.org/10.1111/j.1365-4632.2011.05117.x PMid:22998455

Ziemer M. Delayed-type cutaneous drug reactions. Pathogenesis, clinical features and histology. Hautarzt. 2014;65:397-408. https://doi.org/10.1007/s00105-013-2696-9 PMid:24820797

Tan SC, Tan JW. Symmetrical drug-related intertriginous and flexural exanthema. Curr Opin Allergy Clin Immunol. 2011;11:313-318. https://doi.org/10.1097/ACI.0b013e3283489d5f PMid:21659857

Zheng Y, Zhang J, Chen H, Lai W, Maibach HI. Terbinafine-induced lichenoid drug eruption. Cutan Ocul Toxicol. 2017;36:101-103. https://doi.org/10.3109/15569527.2016.1160101 PMid:26938740